Sentences with phrase «of a drug company since»

LONDON / NEW YORK / TOKYO, April 25 - Rare disease specialist Shire said on Wednesday it was willing to recommend a sweetened $ 64 billion offer from Japan's Takeda Pharmaceutical Co to shareholders, in what would be the biggest acquisition of a drug company since 2000..

LONDON / NEW YORK / TOKYO Rare disease specialist Shire said on Wednesday it was willing to recommend a sweetened $ 64 billion offer from Japan's Takeda Pharmaceutical Co to shareholders, in what would be the biggest acquisition of a drug company since 2000.

LONDON / NEW YORK / TOKYO (Reuters)- Rare disease specialist Shire said on Wednesday it was willing to recommend a sweetened $ 64 billion offer from Japan's Takeda Pharmaceutical Co to shareholders, in what would be the biggest acquisition of a drug company since 2000.

Not exact matches

On the surface, Papa seems to have gotten an extraordinarily generous deal to turn around the beleaguered drug company: Not only is his salary more than twice what it was when he was CEO of Perrigo (prgo), a company nearly three times as valuable as Valeant (vrx), it's also especially good considering Valeant's stock price has fallen nearly 67 % since he took over.

Since it takes several rounds of discussions to understand something as complicated as drug development, this was a boon to fledgling biopharma companies, and VC funding in the space was booming by 2013.

Both companies have since rolled back their price increases, and experts say that while drug prices will continue to rise the practice of hiking prices purely for profit may be on the wane.

Eagle's Sassouni pointed out that since the big drug companies are losing billions of dollars every year to generic versions and have little to spend on their own research and development, they are looking to buy smaller biotechnology companies that are developing their own products.

Shares of the drug company have falling since the middle of last year on allegations of account fraud and price gouging.

Drug makers have asserted that benefits managers, who negotiate rebates and discounts with drug makers and then partially pass those savings on to insurance companies and consumers, are part of the reason that list prices have risen so much, since biopharma companies must incorporate the expected future discounts into their pricing strategDrug makers have asserted that benefits managers, who negotiate rebates and discounts with drug makers and then partially pass those savings on to insurance companies and consumers, are part of the reason that list prices have risen so much, since biopharma companies must incorporate the expected future discounts into their pricing strategdrug makers and then partially pass those savings on to insurance companies and consumers, are part of the reason that list prices have risen so much, since biopharma companies must incorporate the expected future discounts into their pricing strategies.

The price of the EpiPen has soared 500 % since generic drug company Mylan (myl) bought the treatment nine years ago.

However, seeing a high number shouldn't be all that surprising, especially since almost half of the companies the biotech fund holds don't even have a drug on the market yet, so profits could be a long ways away — and this is just the nature of the industry.

Since the late 1990s, Huntingdon Life Sciences — a company that conducts testing of substances on animals mandated by the Environmental Protection Agency and the Food and Drug Administration — has become a proving ground for increasingly aggressive tactics by animal - rights militants.

The Federal Register notice, which has been expected for months, follows a Senate investigation that since last summer has identified several prominent academic psychiatrists who apparently failed to report to their institutions hundreds of thousands of dollars that they earned from drug companies.

A company called Pharmasset had been looking at a group of drugs known as nucleotide analogues, which met some of these criteria, since the mid-2000s.

Since then, in response to pressures from legislators, patient advocates, and pharmaceutical companies, the agency has continued to develop a variety of fast - track pathways that expedite the approval of new drugs and medical devices.

He says HGS was getting «diminishing returns» from its investment in TIGR since Venter had steered his outfit into sequencing organisms of little medical importance, and into human genome sequencing, also of limited value for a company like HGS that is interested in genes as drug targets (not untranslated DNA that makes up most of the genome).

And, naturally, the drug companies don't want you to know that part of the science because it would severely limit the number of people going on cholesterol - lowering drugs, since statins do not modulate the size of the particles.

Now, we have one of the first peer - reviewed studies looking at the effects of coconut oil on Alzheimer's, but since it does not benefit drug companies, do not expect to see this research promoted in the corporate - sponsored «mainstream» media.

Since 2015 there have been a few pharmaceutical companies working on a new cholesterol - lowering drug type as a replacement for the older class of statin drugs, such as Lipitor.

Parent company Eli Lilly reported Oct. 24 that it is weighing the future of Elanco Animal Health, a veterinary drug and vaccines division that has grown since 2014 through three acquisitions.

The company's founder Robert Niznik — who in 2011 was a 21 - year - old New York Law School student — is now CEO of a drug and alcohol detox center in Miami, according to his LinkedIn profile, and has been since sometime in 2013.

The majority also found the Policy's anti-drug position was not indirect discrimination since it was not the result of arbitrariness or stereotypical thinking, but rooted in the fact the Company's industry is safety - sensitive and operating machinery while under the influence of drugs poses a real risk.